G Folprecht Selected Research

Stomach Neoplasms (Stomach Cancer)

2/2010

Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Folprecht Research Topics

Disease

12	Neoplasms (Cancer) 11/2022 - 01/2009
12	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 06/2004
11	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2004
3	Colonic Neoplasms (Colon Cancer) 01/2018 - 12/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2022
2	Rectal Neoplasms (Rectal Cancer) 01/2018 - 01/2004
2	Diarrhea 01/2016 - 03/2006
2	Carcinoma (Carcinomatosis) 01/2009 - 01/2004
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2021
1	Residual Neoplasm 05/2018
1	Hypertension (High Blood Pressure) 01/2016
1	Proteinuria 01/2016
1	Pulmonary Embolism 01/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 11/2013
1	Hypoxia (Hypoxemia) 10/2013
1	Stomach Neoplasms (Stomach Cancer) 02/2010
1	Peritoneal Neoplasms 01/2007

Drug/Important Bio-Agent (IBA)

9	Cetuximab (Erbitux)FDA Link 10/2021 - 03/2006
5	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 06/2004
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 06/2004
5	Leucovorin (Folinic Acid)FDA Link 01/2016 - 06/2004
3	Irinotecan (Camptosar)FDA LinkGeneric 06/2013 - 06/2004
2	ErbB Receptors (EGF Receptor)IBA 10/2021 - 03/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 09/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2013 - 09/2012
2	vatalanib (PTK787)IBA 10/2013 - 09/2012
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Thymidylate SynthaseIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2018
1	afliberceptIBA 01/2016
1	Codon (Codons)IBA 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 10/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2013
1	Phosphotransferases (Kinase)IBA 06/2013
1	regorafenibIBA 06/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2009
1	Carboplatin (JM8)FDA LinkGeneric 01/2009
1	PlatinumIBA 01/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2009
1	Gemcitabine FDA Link 01/2009
1	taxaneIBA 01/2009
1	Monoclonal AntibodiesIBA 06/2004

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 04/2022 - 09/2004
10	Therapeutics 01/2016 - 01/2004
4	Neoadjuvant Therapy 11/2011 - 06/2004
3	Adjuvant Chemotherapy 04/2022 - 01/2018
2	Metastasectomy 10/2013 - 06/2010
1	Aftercare (After-Treatment) 05/2018
1	Chemoradiotherapy 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018
1	Lasers (Laser) 10/2013
1	Radiotherapy 01/2004
1	Adjuvant Chemoradiotherapy 01/2004